Inhibition of UDP-glucose dehydrogenase by 6-Thiopurine and its oxidative metabolites: possible mechanism for its interaction within the bilirubin excretion pathway and 6-Thiopurine associated toxicity
Doctor of Philosophy === Department of Chemistry === Ryan Rafferty === 6-Thiopurine (6TP), or 6-mercaptopurine, is an actively prescribed drug in the treatment of acute lymphocytic leukemia since 1952. Although 6TP has beneficial and promising therapeutic uses, severe toxicities are associated with...
Main Author: | Weeramange, Chamitha Janani |
---|---|
Language: | en |
Published: |
2018
|
Subjects: | |
Online Access: | http://hdl.handle.net/2097/38874 |
Similar Items
-
Genetically Raised Circulating Bilirubin Levels and Risk of Ten Cancers: A Mendelian Randomization Study
by: Nazlisadat Seyed Khoei, et al.
Published: (2021-02-01) -
ASSOCIATION OF UGT1A1 GLY71ARG WITH URINE UROBILINOGEN
by: HAMAJIMA, NOBUYUKI, et al.
Published: (2011) -
Genetically Regulated Bilirubin and Risk of Non-alcoholic Fatty Liver Disease: A Mendelian Randomization Study
by: Lei Luo, et al.
Published: (2018-12-01) -
Gilbert’s Syndrome and the Gut Microbiota – Insights From the Case-Control BILIHEALTH Study
by: Patrick A. Zöhrer, et al.
Published: (2021-09-01) -
A Comparison between Transcutaneous Bilirubin (TcB) and Total Serum Bilirubin (TSB) Measurements in Term Neonates
by: Majid Mansouri, et al.
Published: (2015-05-01)